会社概要
- 正式社名: BLIS Technologies Ltd
- 登録国: New Zealand
- 住所: 10, Birch St,Dunedin,PO Box No 2208,, Dunedin
- 従業員数: 25 - 49
説明:
Founded on the research of Professor John Tagg at the University of Otago, New Zealand, and the discovery of oral probiotic strains BLIS K12 and BLIS M18, BLIS Technologies' strains are backed by more than 30 years of research, over 70 clinical trials and an IP-protected supply chain. The company offers partners both ingredient and finished products across health areas including immunity, teeth and gums, mouth, throat and oral health.
事業活動
ATC分類(解剖治療化学分類)
製造業者
先発品原薬
製造業者
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
当社の製品・サービス
認証
ISO
証明
CPHI Korea 2026
08/2026 – 08/2026
CPHI Korea 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す